Will the Phase 3 trial "Effect of Colchicine on Perioperative Anti-inflammatory Organ Injury in Cardiac Surgery" reach primary completion on or before Aug 31, 2026?

Resolves Yes if ClinicalTrials.gov record NCT06118034 (The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School) shows an actual primary completion date on or before Aug 31, 2026. Registered date at generation: Aug 31, 2026.

Outcome verified from clinicaltrials.gov.

1. Market open

   Jul 17, 2026, 7:40 AM UTC
2. Market closes

   By Aug 31, 2026, 11:59 PM UTC
3. Projected payout

   Shortly after the market closes

Trading on material non-public information is prohibited. Markets are for entertainment and informational purposes using free Pulse Credits — no real-money wagering. If you believe a participant has acted on inside information, please report it.